The study looked for an optimal set of genes differentiating between papillary thyroid cancer
BackgroundRecently high-throughput sequencing (HTS) using next generation sequencing techniques became useful in digital gene expression profiling.Our study introduces analysis options for HTS data based on mapping to miRBase or counting and grouping of identical sequence reads. Those approaches allow a hypothesis free detection of miRNA differential expression.MethodsWe compare our results to microarray and qPCR data from one set of RNA samples. We use Illumina platforms for microarray analysis and miRNA sequencing of 20 samples from benign follicular thyroid adenoma and malignant follicular thyroid carcinoma. Furthermore, we use three strategies for HTS data analysis to evaluate miRNA biomarkers for malignant versus benign follicular thyroid tumors.ResultsHigh correlation of qPCR and HTS data was observed for the proposed analysis methods. However, qPCR is limited in the differential detection of miRNA isoforms. Moreover, we illustrate a much broader dynamic range of HTS compared to microarrays for small RNA studies. Finally, our data confirm hsa-miR-197-3p, hsa-miR-221-3p, hsa-miR-222-3p and both hsa-miR-144-3p and hsa-miR-144-5p as potential follicular thyroid cancer biomarkers.ConclusionsCompared to microarrays HTS provides a global profile of miRNA expression with higher specificity and in more detail. Summarizing of HTS reads as isoform groups (analysis pipeline B) or according to functional criteria (seed analysis pipeline C), which better correlates to results of qPCR are promising new options for HTS analysis. Finally, data opens future miRNA research perspectives for HTS and indicates that qPCR might be limited in validating HTS data in detail.
Selection of novel molecular markers is an important goal of cancer genomics studies. The aim of our analysis was to apply the multivariate bioinformatical tools to rank the genes -potential markers of papillary thyroid cancer (PTC) according to their diagnostic usefulness. We also assessed the accuracy of benign/malignant classification, based on gene expression profiling, for PTC. We analyzed a 180-array dataset (90 HG-U95A and 90 HG-U133A oligonucleotide arrays), which included a collection of 57 PTCs, 61 benign thyroid tumors, and 62 apparently normal tissues. Gene selection was carried out by the support vector machines method with bootstrapping, which allowed us 1) ranking the genes that were most important for classification quality and appeared most frequently in the classifiers (bootstrap-based feature ranking, BBFR); 2) ranking the samples, and thus detecting cases that were most difficult to classify (bootstrap-based outlier detection). The accuracy of PTC diagnosis was 98.5% for a 20-gene classifier, its 95% confidence interval (CI) was 95.9-100%, with the lower limit of CI exceeding 95% already for five genes. Only 5 of 180 samples (2.8%) were misclassified in more than 10% of bootstrap iterations. We specified 43 genes which are most suitable as molecular markers of PTC, among them some well-known PTC markers (MET, fibronectin 1, dipeptidylpeptidase 4, or adenosine A1 receptor) and potential new ones (UDP-galactose-4-epimerase, cadherin 16, gap junction protein 3, sushi, nidogen, and EGF-like domains 1, inhibitor of DNA binding 3, RUNX1, leiomodin 1, F-box protein 9, and tripartite motif-containing 58). The highest ranking gene, metallophosphoesterase domain-containing protein 2, achieved 96.7% of the maximum BBFR score.
The paper concerns the problem of fitting mathematical models of cell signaling pathways. Such models frequently take the form of sets of nonlinear ordinary differential equations. While the model is continuous in time, the performance index used in the fitting procedure, involves measurements taken at discrete time moments. Adjoint sensitivity analysis is a tool, which can be used for finding the gradient of a performance index in the space of parameters of the model. In the paper a structural formulation of adjoint sensitivity analysis called the Generalized Backpropagation Through Time (GBPTT) is used. The method is especially suited for hybrid, continuous-discrete time systems. As an example we use the mathematical model of the NF-kB regulatory module, which plays a major role in the innate immune response in animals.
BackgroundRecent studies suggest that gene expression profiles are a promising alternative for clinical cancer classification. One major problem in applying DNA microarrays for classification is the dimension of obtained data sets. In this paper we propose a multiclass gene selection method based on Partial Least Squares (PLS) for selecting genes for classification. The new idea is to solve multiclass selection problem with the PLS method and decomposition to a set of two-class sub-problems: one versus rest (OvR) and one versus one (OvO). We use OvR and OvO two-class decomposition for other recently published gene selection method. Ranked gene lists are highly unstable in the sense that a small change of the data set often leads to big changes in the obtained ordered lists. In this paper, we take a look at the assessment of stability of the proposed methods. We use the linear support vector machines (SVM) technique in different variants: one versus one, one versus rest, multiclass SVM (MSVM) and the linear discriminant analysis (LDA) as a classifier. We use balanced bootstrap to estimate the prediction error and to test the variability of the obtained ordered lists.ResultsThis paper focuses on effective identification of informative genes. As a result, a new strategy to find a small subset of significant genes is designed. Our results on real multiclass cancer data show that our method has a very high accuracy rate for different combinations of classification methods, giving concurrently very stable feature rankings.ConclusionsThis paper shows that the proposed strategies can improve the performance of selected gene sets substantially. OvR and OvO techniques applied to existing gene selection methods improve results as well. The presented method allows to obtain a more reliable classifier with less classifier error. In the same time the method generates more stable ordered feature lists in comparison with existing methods.ReviewersThis article was reviewed by Prof Marek Kimmel, Dr Hans Binder (nominated by Dr Tomasz Lipniacki) and Dr Yuriy Gusev
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.